Neurotrophic factors and their effects in the treatment of multiple sclerosis

Razavi, Shahnaz; Nazem, Ghasemi; Mardani, Mohammad; Esfandiari, Ebrahim; Salehi, Hossein; Esfahani, Sayyed Hamid Zarkesh

Neurotrophic factors and their effects in the treatment of multiple sclerosis

Authors

¹ Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

² epartment of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

³ Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran

Abstract

Neurotrophins are small molecules of polypeptides, which include nerve growth factor (NGF) family, glial cell line-derived neurotrophic factor (GDNF) family ligands, and neuropoietic cytokines. These factors have an important role in neural regeneration, remyelination, and regulating the development of the peripheral and central nervous systems (PNS and CNS, respectively) by intracellular signaling through specific receptors. It has been suggested that the pathogenesis of human neurodegenerative disorders may be due to an alteration in the neurotrophic factors and their receptors. The use of neurotrophic factors as therapeutic agents is a novel strategy for restoring and maintaining neuronal function during neurodegenerative disorders such as multiple sclerosis. Innate and adaptive immune responses contribute to pathology of neurodegenerative disorders. Furthermore, autoimmune and mesenchymal stem cells, by the release of neurotrophic factors, have the ability to protect neuronal population and can efficiently suppress the formation of new lesions. So, these cells may be an alternative source for delivering neurotrophic factors into the CNS.

Keywords

References

1.	Hardy K, Spanos S. Growth factor expression and function in the human and mouse pre implantation embryo. J Endocrinol 2002;2:221-36.
2.	Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R. Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases. Ann Neurol 2003;53:292-304.
3.	Zhou Z, Chen H, Zhang K, Yang H, Liu J, Huang Q. Protective effect of nerve growth factor on neurons after traumatic brain injury. J Basic Clin Physiol Pharmacol 2003;14:217-24.
4.	Chiaretti A, Antonelli A, Genovese O, Fernandez E, Giuda D, Mariotti P, et al. Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates double cortin expression in two infants with hypoxic-ischemic brain injury. Neurol Res 2008;30:223-8.
5.	Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, et al. Production of neurotrophins by activated T cells: Implications for neuroprotective autoimmunity. J Autoimmun 2000;15:331-45.
6.	Chao MV. Neurotrophin receptors: A window into neuronal differentiation. Neuron 1992;9:583-93.
7.	Barbacid M. The Trk family of neurotrophin receptors. Neurobiol 1994;25:1386-403.
8.	Chao MV. The p75 neurotrophin receptor. Neurobiol 1994;25:1373-385.
9.	Vega JA, Garcia-Suarez O, Hannestad J, Perez- Perez M, Germana A. Neurotrophins and the immune system. J Anat 2003;203:1-19.
10.	Götz R, Köster R, Winkler C, Raulf F, Lottspeich F, Schartl M, et al. Neurotrophin-6 is a new member of the nerve growth factor family. Nature 1994;6503:266-9.
11.	Markus A, Patel TD, Snider WD. Neurotrophic factors and axonal growth. Curr Opin Neurobiol 2002;5:523-31.
12.	Levi-Montalcini R. The nerve growth factor: Thirty-five years later. EMBO J 1987;5:1145-54.
13.	Sofroniew MV, Howe CL, Mobley WC. Nerve growth factors signalling, neuroprotection and neural repair. Annu Rev Neurosci 2001;24:1217-81.
14.	Castellanos MR, Aguiar J, Fernandez CI, Almaguer W, Mejias C, Varela A. Evaluation of the neurorestorative effects of the murine beta-nerve growth factor infusions in old rat with cognitive deficit. Biochem Biophys Res Commun 2003;312:867-72.
15.	Xia YX, Ikeda T, Xia XY, Ikenoue T. Differential neurotrophin levels in cerebrospinal fluid and their changes during development in newborn rat. Neurosci Lett 2000;280:220-2.
16.	Shooter EM. Early days of the nerve growth factor proteins. Annu Rev Neurosci 2001;24:601-29.
17.	Frossard N, Freund V, Advenier C. Nerve growth factor and its receptors in asthma and inflammation. Eur J Pharmacol 2004;500:453-65.
18.	Rankin SL, Guy CS, Mearow KM. TrkA NGF receptor plays a role in the in the modulation of p75NTR expression. Neurosci Lett 2005;383:305-10.
19.	Sofroniew MV, Howe CL, Mobley WC. Nerve growth factors signalling, neuroprotection and neural repair. Annu Rev Neurosci 2001;24:1217-81.
20.	Althaus HH, Kloppner S, Schmidt-Schultz T, Schwartz P. Nerve growth factor induces proliferation and enhances fiber regeneration in oligodendrocytes isolated from adult pig brain. Neurosci Lett 1992;135:219-23.
21.	Urschel BA, Hulsebosch CE. Schwann cell-neuronal interactions in the rat involve nerve growth factor. J Comp Neurol 1990;296:114-22.
22.	Calza L, Giardino L, Pozza M, Micera A, Aloe L. Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A 1997;94:3368-73.
23.	Salehi A, Delcroix JD, Swaab DF. Alzheimer's disease and NGF signaling. J Neural Transm 2004;111:323-45.
24.	Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, et al. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 2000;191:1799-806.
25.	Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;5:549-53.
26.	Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 2001;24:677-736.
27.	Kerschensteiner M, Gallmeier E, Behrens L. Activated human Tcells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation. J Exp Med 1999;189:865-70.
28.	Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289-317.
29.	Burbach GJ, Hellweg R, Haas CA, Del TD, Deicke U, Abramowski D, et al. Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J Neurosci 2004;24:2421-30.
30.	Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H. BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells. Brain 2002;125:75-85.
31.	Vargas-Leal V, Bruno R, Derfuss T, Krumbholz M, Hohlfeld R, Meinl E. Expression and function of glial cell line-derived neurotrophic factor family ligands and their receptors on human immune cells. J Immunol 2005;4:2301-8.
32.	Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuro Report 1995;6:61053-7.
33.	Studer L, Spenger C, Seiler RW, Othberg A, Lindvall O, Odin P. Effect of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon. Exp Brain Res 1996;108:328-36.
34.	Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995;18:223-53.
35.	Klein R, Conway D, Parada LF, Barbacid MC. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 1990 18;61:647-56.
36.	Angelucci F, Brenè S, Mathé AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005;4:345-52.
37.	Gravel C, Götz R, Lorrain A, Sendtner M. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat Med 1997;3:765-70.
38.	Kobayashi NR, Fan DP, GiehlK M, Bedard AM, Wiegand SJ, Tetzlaff W. BDNF and NT-4/5prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Ta1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci 1997;17:9583-95.
39.	Mc Tigue DM, Horner PJ, Stokes BT, Gage FH. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 1998;18:5354-65.
40.	Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992;360:753-5.
41.	Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM, et al. Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science 1990;247:1146-451.
42.	Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H. Molecular cloning and neurotrophic activities of a protein with structural imilarities to nerve growth factor: Developmental and topographical expression in the brain. Proc Natl Acad Sci 1990;87:5454-8.
43.	Holtzman DM, Mobley WC. Neurotrophic factors and neurologic disease. West J Med 1994;161:246-54.
44.	Thoenen H. The changing scene of neurotrophic factors. Trends Neurosci 1991;14:165-70.
45.	Arenas E, Persson H. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 1994;367:368-71.
46.	Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994;369:658-61.
47.	Hallbook F, Ibanez CF, Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991;6:845-58.
48.	Kobayashi NR, Fan DP, Giehl KM, Bedard AM, Wiegand SJ, Tetzlaff W. BDNF and NT-4/5prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Ta1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci 1997;17:9583-95.
49.	Junger H, Varon S. Neurotrophin-4 (NT-4) and glial cell line-derived neurotrophic factor (GDNF) promote the survival of corticospinal motorneurons of neonatal rats in vitro. Brain Res 1997;762:56-60.
50.	Loma I, Heyman R. Multiple sclerosis: Pathogenesis and treatment. Curr Neuropharmacol 2011;3:409-16.
51.	Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nervesection. Nature 1992;360:757-9.
52.	Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: Therapeutic implications in a model of multiple sclerosis. Brain 2010;8:2248-63.
53.	Sarchielli P, Greco L, Stipa A, Floridi A, Gallai V. Brain-derived neurotrophic factor in patients with multiple sclerosis. J Neuroimmunol 2002;132:180-8.
54.	Kramer R, Zhang Y, Gehrmann J, Gold R, Thoenen H, Wekerle H. Gene transfer through the blood nerve barrier: Nerve growth factor engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nat Med 1995;1:1162-6.
55.	Caggiula M, Batocchi AP, Frisullo G, Angelucci F, Patanella AK, Sancricca C, et al. Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy. Clin Immunol 2006;118:77-82.
56.	Chen M, Valenzuela RM, Dhib-Jalbut S. Glatiramer acetate reactive T-cells produce brain derived neurotrophic factor (BDNF). J Neurol Sci 2003;140:37-44.
57.	Azoulay D, Vachapova V, Shihman B, Miler A, Karni A. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate. J Neuroimmunol 2005;167:215-8.
58.	Aharoni R, Eilam R, Domev H, Labunskay G, Sela M, Arnon R. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc Natl Acad Sci U S A 2005;102:19045-50.
59.	De Santi L, Annunziata P, Sessa E, Bramanti P. Brainderived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neurol Sci 2009;287:17-26.
60.	Colombo E, Cordiglieri C, Melli G, Newcombe J, Krumbholz M, Parada LF, et al. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J Exp Med 2012;209:521-35.
61.	Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB, et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005;195:16-26.
62.	Ghasemi N, Razavi S, Mardani M, Esfandiari E, Salehi H, Zarkesh Esfahani SH. Transplantation of human adipose-derived stem cells enhances remyelination in lysolecithin-induced focal demyelination of rat spinal cord. Mol Biotechnol. 2014; 56:470-8.
63.	Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009;27:2624-35.
64.	VonDran MW, Singh H, Honeywell JZ, Dreyfus CF. Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion. J Neurosci 2011;31:14182-90.
65.	Eigenbrot C, Gerber N. X-ray structure of glial cell derived neurotrophic factor at 1.9 AÊ resolution and implications for receptor binding. Nat Struct Biol 1997;4:435-8.
66.	Airaksinen MS, Saarma M. The GDNF family: Signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002;3:383-94.
67.	Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 1996;85:1113-24.
68.	Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurones. Science 1993;260:1130-2.
69.	Ramer MS, Priestley JV, McMahon SB. Functional regeneration of sensory axons into the adult spinal cord. Nature 2000;6767:312-6.
70.	Meng X, de Rooij DG, Westerdahl K, Saarma M, Sariola H. Promotion of seminomatous tumors by targeted over expression of glial cell line-derived neurotrophic factor in mouse testis. Cancer Res 2001;61:3267-71.
71.	Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, et al. Characterization of a multicomponent receptor for GDNF. Nature 1996;382:80-3.
72.	Heuckeroth RO, Enomoto H, Grider JR, Golden JP, Hanke JA, Jackman A, et al. Gene targeting reveals a critical role forneurturin in the development and maintenance of enteric, sensory and parasympathetic neurons. Neuron 1999;22:253-63.
73.	Burazin TC, Gundlach AL. Localizationof GDNF/neurturin receptor (c ret, GFRalpha-1and alpha-2) mRNAs in post natal rat brain: Differential regional and temporal expression in hippocampus, cortex and cerebellum. Mol Brain Res 1999;73:151-71.
74.	Horger BA, Nishimura MC, Armanini MP, Wang LC, Poulsen KT, Rosenblad C, et al. Neurturin exertspotentactionsonsur vivalandfunction of midbraindopami - nergicneurons. J Neurosci 1998;18:4929-37.
75.	Gasmi M, Herzog CD, Brandon EP, Cunningham JJ, Ramirez GA, Ketchum ET, et al. Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neurondegeneration in Parkinson's disease. Mol Ther 2007;15:62-8.
76.	Viglietto G, Dolci S, Bruni P, Baldassarre G, Chiariotti L, Melillo RM, et al. Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of RET-expressing spermatogonia. Int J Oncol 2000;16:689-94.
77.	Baloh RH, Tansey MG, Lampe PA, Fahrner TJ, Enomoto H, Simburger KS, et al. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRa3-RET receptor complex. Neuron 1998;21:1291-302.
78.	Milbrandt J, De Sauvage FJ, Fahrner TJ, Baloh RH, Leitner ML, Tansey MG, et al. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 1998;20:245-53.
79.	Airaksinen MS, Titievsky A, Saarma M. GDNF family neurotrophic factor signalling: Four masters one servant? Mol Cell Neurosci 1999;13:313-25.
80.	Bespalov MM, Sidorova YA, Tumova S, Ahonen-Bishopp A, Magalhães AC, Kulesskiy E, et al. Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J Cell Biol 2011;10:153-69.
81.	Zihlmann KB, Ducray AD, Schaller B, Huber AW, Krebs SH, Andres RH, et al. The GDNF family members neurturin, artemin and persephin promote the morphological differentiation of cultured ventral mesencephalic dopaminergic neurons. Brain Res Bull 2005;68:42-53.
82.	Lindahl M, Timmusk T, Rossi J, Saarma M, Airaksinen MS. Expression and alternative splicing of mouse Gfra4 suggest roles in endocrine cell development. Mol Cell Neurosci 2000;15:522-33.
83.	Lindahl M, Poteryaev D, Yu L, Arumäe U, Timmusk T, Bongarzone I, et al. Human glial cell line-derivedneurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells. J Biol Chem 2001;276:9344-51.
84.	Lindfors PH, Lindahl M, Rossi J, Saarma M, Airaksinen MS. Ablation of persephin receptor glial cell line-derived neurotrophic factor family receptoralpha4 impairs thyroid calcitonin production in young mice. Endocrinology 2006;147:2237-44.
85.	Ho TW, Bristol LA, Coccia C, Li Y, Milbrandt J, Johnson E, et al. TGF beta trophic factors differentially modulate motor axon outgrowth and protection from excitotoxicity. Exp Neurol 2000;161:664-75.
86.	Tomac AC, Agulnick AD, Haughey N, Chang CF, Zhang Y, Bäckman C, et al. Effects of cerebral ischemia in mice deficient in persephin. Proc Natl Acad Sci 2002;99:9521-6.
87.	Bilang-Bleuel A, Revah F, Colin P, Locquet I, Robert JJ, Mallet J, et al. Intra striatal injection of an adenoviral vector expressing glial-cell-line derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci U S A 1997;94:8818-23.
88.	Gash DM, Zhang Z, Ai Y, Grondin R, Coffey R, Gerhardt GA. Trophic factor distribution predicts functional recovery in parkinsonian monkeys. Ann Neurol 2005;58:224-33.
89.	Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, et al. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994;266:1062-4.
90.	Arenas E, Trupp M, Åkerud P, Ibañéz CF. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 1995;15:1465-73.
91.	Bauer S, Patterson PH. Leukemia inhibitory factor promotes neural stem cell self-renewal in the adult brain. J Neurosci 2006;26:12089-99.
92.	Lin LF, Mismer D, Lile JD, Armes LG, Butler ET, Vannice JL, et al. Purification, cloning and expression of ciliary neurotrophic factor (CNTF). Science 1989;246:1023-5.
93.	Ernsberger U, Sendtner M, Rohrer H. Proliferation and differentiation of embryonic chick sympathetic neurons: Effects of ciliary neurotrophic factor. Neuron 1989;2:1275-84.
94.	Saadat S, Sendtner M, Rohrer H. Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture. J Cell Biol 1989;708:1807-16.
95.	Lillien LE, Sendtner M, Rohrer H, Hughes SM, Raff MC. Type-2 astrocyte development in rat brain cultures is initiated by a CNTF-like protein produced by type-l astrocytes. Neuron 1988;1:485-94.
96.	Stockli KA. Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature 1989;342:920-3.
97.	Shimazaki T, Shingo T, Weiss S. The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells. J Neurosci 2001;21:7642-53.
98.	Stahl N, Yancopoulos CD. The alphas, betas, and kinases of cytokine receptor complexes. Cell 1993;74:587-90.
99.	Davis S, Yancopoulos GD. The molecular biology of the CNTF receptor. Curr Opin Cell Biol 1993;2:281-5.
100.	Williams RL. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988;336:684-7.
101.	Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7.
102.	Carpenter MK. In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol 1999;158:265-78.
103.	Wright LS. Gene expression in human neural stem cells: Effects of leukemia inhibitory factor. J Neurochem 2003;86:179-95.
104.	Galli R, Pagano SF, Gritti A, Vescovi AL. Regulation of neuronal differentiation in human CNS stem cell progeny by leukemia inhibitory factor. Dev Neurosci 2000;22:86-95.
105.	Pagano SF, Impagnatiello F, Girelli M, Cova L, Grioni E, Onofri M, et al. Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 2000;18:295-300.
106.	Bonaguidi MA, McGuire T, Hu M, Kan L, Samanta J, Kessler JA. LIF and BMP signaling generate separate and discrete types of GFAP expressing cells. Development 2005;132:5503-14.
107.	Pitman M, Emery B, Binder M, Wang S, Butzkueven H, Kilpatrick TJ. LIF receptor signaling modulates neural stem cell renewal. Mol Cell Neurosci 2004;27:255-66.
108.	Razavi S, Mardani M, Kazemi M, Esfandiari E, Narimani M, Esmaeili A, et al. Effect of leukemia inhibitory factor on the myelinogenic ability of Schwann-like cells induced from human adipose-derived stem cells. Cell Mol Neurobiol 2013;2:283-90.
109.	Gearing DP, Thut CJ, VandenBos T, Gimpel SD, Delaney PB, King J, et al. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gpl30. EMBO J 1991;70:2839-48.
110.	Marmur R, Kessler JA, Zhu G, Gokhan S, Mehler MF. Differentiation of oligodendroglial progenitors derived from cortical multipotent cells requires extrinsic signals including activation of gp130/LIF_ receptors. J Neurosci 1998;18:9800-11.
111.	Schonrock LM, Gawlowski G, Bruck W. Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett 2000;294:45-8.
112.	Vanderlocht J, Hellings N, Hendriks JJ, Vandenabeele F, Moreels M, Buntinx M, et al. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-α-induced oligodendrocyte apoptosis. J Neurosci Res 2006;83:763-74.
113.	Butzkueven H, Emery B, Ciprian T, Marriott MP, Kilpatrick TJ. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 2006;53:696-703.
114.	Giess R, Mäurer M, Linker R, Gold R, Warmuth-Metz M, Toyka KV, et al. Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Arch Neurol 2002;59:407-9.
115.	Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, et al. Astrocytes promote myelination in response to electrical impulses. Neuron 2006;49:823-32.
116.	Dell'Albani P, Kahn MA, Cole R, Condorelli DF, Giuffrida-Stella AM, deVellis J. Oligodendroglial survival factors, PDGF-AA and CNTF, activate similar JAK/STAT signaling pathways. J Neurosci Res 1998;54:191-205.
117.	Salehi Z, Hadiyan SP, Navidi R. Ciliary neurotrophic factor role in myelin oligodendrocyte glycoprotein expression in Cuprizone-induced multiple sclerosis mice. Cell Mol Neurobiol 2013;33:531-5.
118.	Stankoff B, Aigrot MS, Noël F, Wattilliaux A, Zalc B, Lubetzki C. Ciliary neurotrophic factor (CNTF) enhances myelin formation: A novel role for CNTF and CNTF-related molecules. J Neurosci 2002;2:9221-7.
119.	Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. J Neuroimmunol 2009;206:58-69.
120.	Razavi S, Razavi MR, Zarkesh Esfahani H, Kazemi M, Mostafavi FS. Comparing brain-derived neurotrophic factor and ciliary neurotrophic factor secretion of induced neurotrophic factor secreting cells from human adipose and bone marrow-derived stem cells. Dev Growth Differ 2013;55:648-55.

Advanced Biomedical Research